Prenetics Global Ltd (PRE)

Currency in USD
24.0900
-0.1000(-0.41%)
Real-time Data·
PRE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
23.770025.0100
52 wk Range
11.365027.2400
Key Statistics
Prev. Close
24.19
Open
24.7
Day's Range
23.77-25.01
52 wk Range
11.365-27.24
Volume
63.11K
Average Volume (3m)
223.14K
1-Year Change
100.75%
Book Value / Share
5.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
35.8571
Upside
+48.85%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Prenetics Global Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 35.8571
(+48.85% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Craig-Hallum
Buy40.00+66.04%-New Coverage17-09-2026
StoneX
Buy40.00+66.04%40.00Maintain08-09-2026
B.Riley
Buy37.00+53.59%-New Coverage27-08-2026
Benchmark
Buy40.00+66.04%30.00Maintain15-07-2026
Benchmark
Buy30.00+24.53%-New Coverage16-06-2026

Prenetics Global Ltd Earnings Call Summary for Q2/2026

  • Prenetics Q2 EPS of -$0.53 beat estimates by 25%, but revenue of $46.5M missed forecasts by 5.4%, sending shares down 1.91% to $19.
  • Gross margin improved to 65% from 62% YoY; July marked first-ever positive adjusted free cash flow at $20.9M revenue, implying $251M annual run rate.
  • Company raised FY guidance to $220M-$230M revenue; Q3 expected at $63M-$64M with H2 adjusted EBITDA loss improving to -$8M to -$12M range.
  • IM8 wellness segment drove growth with $45M revenue, up 33% sequentially; new products IM8 Hydration (Q4) and Premium Gummies (Q1 2025) not in guidance.
  • Management emphasized marketing efficiency gains and science-based positioning, maintaining 95% direct-to-consumer focus with no near-term retail expansion plans.
Last Updated: 18-08-2026, 07:48 pm
Read Full Transcript

Earnings

Latest Release
18-08-2026
EPS / Forecast
-0.53 / -0.71
Revenue / Forecast
46.5M / 49.15M
EPS Revisions
Last 90 days

PRE Income Statement

Compare PRE to Peers and Sector

Metrics to compare
PRE
Peers
Sector
Relationship
P/E Ratio
−7.3x−4.7x−0.4x
PEG Ratio
−0.300.010.00
Price/Book
4.4x2.7x2.6x
Price / LTM Sales
2.6x1.2x3.0x
Upside (Analyst Target)
49.8%20.2%54.3%
Fair Value Upside
Unlock−6.0%7.2%Unlock

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
7.19K0.04%173.95K
Other Institutional Investors
1.22M7.18%29.42M
Public Companies & Retail Investors
15.71M92.78%380.13M
Total
16.94M100.00%409.72M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Prospect Capital Advisors, LLC1.39%2,35,8005,704
Jane Street Group, LLC1.33%2,25,0935,445

FAQ

What Is the Prenetics Global (PRE) Share Price Today?

The Prenetics Global share price today is 24.0900.

What is the current Prenetics Global (PRE) share price and day range?

As of 21-09-2026, the Prenetics Global share price is 24.0900, with a previous close of 24.1900. The share price has ranged from 23.7700 to 25.0100 today, while the 52-week range spans from 11.3650 to 27.2400.

What Is the Prenetics Global Market Cap?

As of today, Prenetics Global market cap is 409.7200M.

What Is the Prenetics Global (PRE) Share Price Target?

The average 12-month share price target for Prenetics Global is 35.8571, with a high estimate of 40 and a low estimate of 30. 5 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +48.85% Upside potential.

What Is Prenetics Global's Earnings Per Share (TTM)?

The Prenetics Global EPS (TTM) is -3.4876.

When Is the Next Prenetics Global Earnings Date?

Prenetics Global will release its next earnings report on 05-11-2026.

From a Technical Analysis Perspective, Is PRE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does Prenetics Global Trade On?

Prenetics Global is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Prenetics Global?

The stock symbol for Prenetics Global is "PRE."

How Many Times Has Prenetics Global Stock Split?

Prenetics Global has split 2 times.

How Many Employees Does Prenetics Global Have?

Prenetics Global has 98 employees.

What Is the PRE Premarket Price?

PRE's last pre-market stock price is 24.3600. The pre-market share volume is 20.0000, and the stock has changed by 0.1700, or 0.7000%.

What Is the PRE After Hours Price?

PRE's last after hours stock price is 24.3600, the stock has changed by 0.1700, or 0.7000%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.